Atlas Trials

Serum Oxidative Status as a Potential Predictor of Coronary Artery Disease.

Clinical trial NCT03646019 · UNKNOWN

Trial details

NCT number
NCT03646019
Sponsor
Prof. Tony hayek MD
Status
UNKNOWN
Study type
OBSERVATIONAL
Coronary Artery DiseaseParaoxanase 1Thiobarbituric Acid Reactive SubstancesThiol Groups
Start date
2018-09-01
Primary completion
2019-03-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.